APO Research
Talk to an analyst

APO RESEARCH · REPORT

Botulinum Toxins in Dermatology and Cosmetology

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Botulinum Toxins in Dermatology and Cosmetology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025187 pages

Choose your research edition.

Industry ResearchBotulinum Toxins in Dermatology and Cosmetology Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Botulinum Toxins in Dermatology and Cosmetology Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Botulinum Toxins in Dermatology and Cosmetology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Botulinum Toxins in Dermatology and Cosmetology Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Botulinum Toxins in Dermatology and Cosmetology Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Botulinum Toxins in Dermatology and Cosmetology market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Botulinum Toxins in Dermatology and Cosmetology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Botulinum Toxins in Dermatology and Cosmetology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Botulinum Toxins in Dermatology and Cosmetology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Botulinum Toxins in Dermatology and Cosmetology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Botulinum Toxins in Dermatology and Cosmetology include Merz Pharmaceuticals, Medytox, LIBP, Ipsen, Hugel, Daewoong and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Botulinum Toxins in Dermatology and Cosmetology market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Botulinum Toxins in Dermatology and Cosmetology and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Botulinum Toxins in Dermatology and Cosmetology sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Botulinum Toxins in Dermatology and Cosmetology market size, projected growth trends, production technologies, key applications, and end-use industries.

Botulinum Toxins in Dermatology and Cosmetology Segment by Company

Merz Pharmaceuticals

Medytox

LIBP

Ipsen

Hugel

Daewoong

Allergan

Botulinum Toxins in Dermatology and Cosmetology Segment by Type

50IU/Vial

100IU/Vial

Other

Botulinum Toxins in Dermatology and Cosmetology Segment by Application

Hospital

Beauty Salon

Botulinum Toxins in Dermatology and Cosmetology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botulinum Toxins in Dermatology and Cosmetology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Botulinum Toxins in Dermatology and Cosmetology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botulinum Toxins in Dermatology and Cosmetology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Botulinum Toxins in Dermatology and Cosmetology market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Botulinum Toxins in Dermatology and Cosmetology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Botulinum Toxins in Dermatology and Cosmetology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Botulinum Toxins in Dermatology and Cosmetology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Botulinum Toxins in Dermatology and Cosmetology Industry Trends Table 2. Botulinum Toxins in Dermatology and Cosmetology Industry Drivers Table 3. Botulinum Toxins in Dermatology and Cosmetology Industry Opportunities and Challenges Table 4. Botulinum Toxins in Dermatology and Cosmetology Industry Restraints Table 5. Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Botulinum Toxins in Dermatology and Cosmetology Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Manufacturers Table 9. Global Botulinum Toxins in Dermatology and Cosmetology Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Botulinum Toxins in Dermatology and Cosmetology Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Botulinum Toxins in Dermatology and Cosmetology Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Botulinum Toxins in Dermatology and Cosmetology Manufacturers, Product Type & Application Table 13. Global Botulinum Toxins in Dermatology and Cosmetology Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Botulinum Toxins in Dermatology and Cosmetology by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50IU/Vial Table 17. Major Manufacturers of 100IU/Vial Table 18. Major Manufacturers of Other Table 19. Global Botulinum Toxins in Dermatology and Cosmetology Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2021-2026) & (K Units) Table 21. Global Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2027-2032) & (K Units) Table 22. Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Type (2021-2026) Table 23. Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Type (2027-2032) Table 24. Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2021-2026) & (K Units) Table 26. Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2027-2032) & (K Units) Table 27. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Type (2021-2026) Table 28. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Beauty Salon Table 31. Global Botulinum Toxins in Dermatology and Cosmetology Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2021-2026) & (K Units) Table 33. Global Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2027-2032) & (K Units) Table 34. Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Application (2021-2026) Table 35. Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Application (2027-2032) Table 36. Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2021-2026) & (K Units) Table 38. Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2027-2032) & (K Units) Table 39. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Application (2021-2026) Table 40. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Application (2027-2032) Table 41. Global Botulinum Toxins in Dermatology and Cosmetology Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Botulinum Toxins in Dermatology and Cosmetology Sales by Region (2021-2026) & (K Units) Table 43. Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Region (2021-2026) Table 44. Global Botulinum Toxins in Dermatology and Cosmetology Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Botulinum Toxins in Dermatology and Cosmetology Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Botulinum Toxins in Dermatology and Cosmetology Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2021-2026) & (K Units) Table 48. North America Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2027-2032) & (K Units) Table 49. Europe Botulinum Toxins in Dermatology and Cosmetology Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2021-2026) & (K Units) Table 51. Europe Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2027-2032) & (K Units) Table 58. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Region (2021-2026) Table 62. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Region (2027-2032) Table 63. Merz Pharmaceuticals Company Information Table 64. Merz Pharmaceuticals Business Overview Table 65. Merz Pharmaceuticals Botulinum Toxins in Dermatology and Cosmetology Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merz Pharmaceuticals Botulinum Toxins in Dermatology and Cosmetology Product Portfolio Table 67. Merz Pharmaceuticals Recent Development Table 68. Medytox Company Information Table 69. Medytox Business Overview Table 70. Medytox Botulinum Toxins in Dermatology and Cosmetology Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Medytox Botulinum Toxins in Dermatology and Cosmetology Product Portfolio Table 72. Medytox Recent Development Table 73. LIBP Company Information Table 74. LIBP Business Overview Table 75. LIBP Botulinum Toxins in Dermatology and Cosmetology Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. LIBP Botulinum Toxins in Dermatology and Cosmetology Product Portfolio Table 77. LIBP Recent Development Table 78. Ipsen Company Information Table 79. Ipsen Business Overview Table 80. Ipsen Botulinum Toxins in Dermatology and Cosmetology Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Ipsen Botulinum Toxins in Dermatology and Cosmetology Product Portfolio Table 82. Ipsen Recent Development Table 83. Hugel Company Information Table 84. Hugel Business Overview Table 85. Hugel Botulinum Toxins in Dermatology and Cosmetology Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hugel Botulinum Toxins in Dermatology and Cosmetology Product Portfolio Table 87. Hugel Recent Development Table 88. Daewoong Company Information Table 89. Daewoong Business Overview Table 90. Daewoong Botulinum Toxins in Dermatology and Cosmetology Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Daewoong Botulinum Toxins in Dermatology and Cosmetology Product Portfolio Table 92. Daewoong Recent Development Table 93. Allergan Company Information Table 94. Allergan Business Overview Table 95. Allergan Botulinum Toxins in Dermatology and Cosmetology Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Allergan Botulinum Toxins in Dermatology and Cosmetology Product Portfolio Table 97. Allergan Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Botulinum Toxins in Dermatology and Cosmetology Distributors List Table 101. Botulinum Toxins in Dermatology and Cosmetology Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Botulinum Toxins in Dermatology and Cosmetology Product Image Figure 2. Global Botulinum Toxins in Dermatology and Cosmetology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Botulinum Toxins in Dermatology and Cosmetology Market Size (2021-2032) & (US$ Million) Figure 4. Global Botulinum Toxins in Dermatology and Cosmetology Sales (2021-2032) & (K Units) Figure 5. Global Botulinum Toxins in Dermatology and Cosmetology Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Botulinum Toxins in Dermatology and Cosmetology Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50IU/Vial Image Figure 9. 100IU/Vial Image Figure 10. Other Image Figure 11. Global Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Type (2021-2032) Figure 14. Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Beauty Salon Image Figure 19. Global Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Application (2021-2032) Figure 22. Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Application (2021-2032) Figure 25. North America Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Country (2021-2032) Figure 27. U.S. Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Country (2021-2032) Figure 32. Germany Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Country (2021-2032) Figure 39. China Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Country (2021-2032) Figure 47. Brazil Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Botulinum Toxins in Dermatology and Cosmetology Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Botulinum Toxins in Dermatology and Cosmetology Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Botulinum Toxins in Dermatology and Cosmetology Revenue (2021-2032) & (US$ Million) Figure 58. North America Botulinum Toxins in Dermatology and Cosmetology Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Botulinum Toxins in Dermatology and Cosmetology Revenue (2021-2032) & (US$ Million) Figure 60. Europe Botulinum Toxins in Dermatology and Cosmetology Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Botulinum Toxins in Dermatology and Cosmetology Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Botulinum Toxins in Dermatology and Cosmetology Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 50IU/Vial
  • 100IU/Vial
  • Other
Applications
  • Hospital
  • Beauty Salon
Companies covered
  • Merz Pharmaceuticals
  • Medytox
  • LIBP
  • Ipsen
  • Hugel
  • Daewoong
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Botulinum Toxins in Dermatology and Cosmetology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Botulinum Toxins in Dermatology and Cosmetology Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Botulinum Toxins in Dermatology and Cosmetology Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Botulinum Toxins in Dermatology and Cosmetology Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Botulinum Toxins in Dermatology and Cosmetology Market Dynamics
  1. 2.1 Botulinum Toxins in Dermatology and Cosmetology Industry Trends
  2. 2.2 Botulinum Toxins in Dermatology and Cosmetology Industry Drivers
  3. 2.3 Botulinum Toxins in Dermatology and Cosmetology Industry Opportunities and Challenges
  4. 2.4 Botulinum Toxins in Dermatology and Cosmetology Industry Restraints
3 Botulinum Toxins in Dermatology and Cosmetology Market by Manufacturers
  1. 3.1 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Manufacturers (2021-2026)
  3. 3.3 Global Botulinum Toxins in Dermatology and Cosmetology Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Botulinum Toxins in Dermatology and Cosmetology Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Botulinum Toxins in Dermatology and Cosmetology Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Botulinum Toxins in Dermatology and Cosmetology Manufacturers, Product Type & Application
  7. 3.7 Global Botulinum Toxins in Dermatology and Cosmetology Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Botulinum Toxins in Dermatology and Cosmetology Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Botulinum Toxins in Dermatology and Cosmetology Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Botulinum Toxins in Dermatology and Cosmetology Tier 1, Tier 2, and Tier 3
4 Botulinum Toxins in Dermatology and Cosmetology Market by Type
  1. 4.1 Botulinum Toxins in Dermatology and Cosmetology Type Introduction
  2. 4.1.1 50IU/Vial
  3. 4.1.2 100IU/Vial
  4. 4.1.3 Other
  5. 4.2 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Type
  6. 4.2.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Type (2021-2032)
  8. 4.2.3 Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Type (2021-2032)
  9. 4.3 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Type
  10. 4.3.1 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Type (2021-2032)
  12. 4.3.3 Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Type (2021-2032)
5 Botulinum Toxins in Dermatology and Cosmetology Market by Application
  1. 5.1 Botulinum Toxins in Dermatology and Cosmetology Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Beauty Salon
  4. 5.2 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Application
  5. 5.2.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Application (2021-2032)
  7. 5.2.3 Global Botulinum Toxins in Dermatology and Cosmetology Sales Market Share by Application (2021-2032)
  8. 5.3 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Application
  9. 5.3.1 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Application (2021-2032)
  11. 5.3.3 Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Application (2021-2032)
6 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Region
  1. 6.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Region (2021-2032)
  3. 6.2.1 Global Botulinum Toxins in Dermatology and Cosmetology Sales by Region (2021-2026)
  4. 6.2.2 Global Botulinum Toxins in Dermatology and Cosmetology Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Botulinum Toxins in Dermatology and Cosmetology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Botulinum Toxins in Dermatology and Cosmetology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region
  1. 7.1 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region
  2. 7.1.1 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2021-2026)
  4. 7.1.3 Global Botulinum Toxins in Dermatology and Cosmetology Revenue by Region (2027-2032)
  5. 7.1.4 Global Botulinum Toxins in Dermatology and Cosmetology Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Botulinum Toxins in Dermatology and Cosmetology Revenue (2021-2032)
  8. 7.2.2 North America Botulinum Toxins in Dermatology and Cosmetology Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Botulinum Toxins in Dermatology and Cosmetology Revenue (2021-2032)
  11. 7.3.2 Europe Botulinum Toxins in Dermatology and Cosmetology Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Botulinum Toxins in Dermatology and Cosmetology Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Botulinum Toxins in Dermatology and Cosmetology Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merz Pharmaceuticals
  2. 8.1.1 Merz Pharmaceuticals Company Information
  3. 8.1.2 Merz Pharmaceuticals Business Overview
  4. 8.1.3 Merz Pharmaceuticals Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merz Pharmaceuticals Botulinum Toxins in Dermatology and Cosmetology Product Portfolio
  6. 8.1.5 Merz Pharmaceuticals Recent Developments
  7. 8.2 Medytox
  8. 8.2.1 Medytox Company Information
  9. 8.2.2 Medytox Business Overview
  10. 8.2.3 Medytox Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medytox Botulinum Toxins in Dermatology and Cosmetology Product Portfolio
  12. 8.2.5 Medytox Recent Developments
  13. 8.3 LIBP
  14. 8.3.1 LIBP Company Information
  15. 8.3.2 LIBP Business Overview
  16. 8.3.3 LIBP Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 LIBP Botulinum Toxins in Dermatology and Cosmetology Product Portfolio
  18. 8.3.5 LIBP Recent Developments
  19. 8.4 Ipsen
  20. 8.4.1 Ipsen Company Information
  21. 8.4.2 Ipsen Business Overview
  22. 8.4.3 Ipsen Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ipsen Botulinum Toxins in Dermatology and Cosmetology Product Portfolio
  24. 8.4.5 Ipsen Recent Developments
  25. 8.5 Hugel
  26. 8.5.1 Hugel Company Information
  27. 8.5.2 Hugel Business Overview
  28. 8.5.3 Hugel Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hugel Botulinum Toxins in Dermatology and Cosmetology Product Portfolio
  30. 8.5.5 Hugel Recent Developments
  31. 8.6 Daewoong
  32. 8.6.1 Daewoong Company Information
  33. 8.6.2 Daewoong Business Overview
  34. 8.6.3 Daewoong Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Daewoong Botulinum Toxins in Dermatology and Cosmetology Product Portfolio
  36. 8.6.5 Daewoong Recent Developments
  37. 8.7 Allergan
  38. 8.7.1 Allergan Company Information
  39. 8.7.2 Allergan Business Overview
  40. 8.7.3 Allergan Botulinum Toxins in Dermatology and Cosmetology Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Allergan Botulinum Toxins in Dermatology and Cosmetology Product Portfolio
  42. 8.7.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Botulinum Toxins in Dermatology and Cosmetology Value Chain Analysis
  2. 9.1.1 Botulinum Toxins in Dermatology and Cosmetology Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Botulinum Toxins in Dermatology and Cosmetology Production Mode & Process
  6. 9.2 Botulinum Toxins in Dermatology and Cosmetology Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Botulinum Toxins in Dermatology and Cosmetology Distributors
  9. 9.2.3 Botulinum Toxins in Dermatology and Cosmetology Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst